Six neonates with PA, treated using TH in Paediatric ICU in Opole, Poland in 2018 were included in the study after obtaining the consent of their legal guardians. Inclusion criteria for the TH treatment were in accordance with current recommendations:
1) gestational age at birth ≥ 35 weeks, and
2) birth weight ≥ 1800 g, and
3) Apgar score ≤ 5 in 1st, 3rd, 5th, and 10th minute after birth and / or the need of artificial ventilation for the neurological reasons in the 10th minute after birth, and
4) deep acidosis: pH in the cord or arterial blood ≤ 7,0 and/or Base Excess (BE) ≤ 16 mmol/l in the cord, arterial or venous blood in the 1st hour after birth, and
5) neurological disorders: variable states of consciousness and at least one of the symptoms: muscle hypotension, abnormal reaction to stimuli (including abnormal oculomotor and/or pupillary reflex), no or weak sucking reflex, seizures.
Exclusion criteria were as follows:
1) > 6 hours after birth, and/or
2) gestational age < 35 weeks, and/or
3) birth weight < 1800 g., and/or
4) severe birth defects with poor prognosis, and/or
5) severe coagulopathy, and/or
6) massive intracranial hemorrhage, and/or
7) extremely severe hypoxia with Apgar score = 0 at 10th minute after birth.
Amplitude integrated electroencephalography (aiEEG) was used as an additional criterion for qualifying for TH treatment in doubtful situations.
Newborns after PA admitted to Paediatric ICU were qualified for TH treatment based on clinical/biochemical criteria. Cranial ultrasound, laboratory tests and aiEEG were performed within 30 minutes of admission. After confirming the indications and ruling out contraindications, TH was started with the Olympic Cool-Cap (Olympic Medical, division of Natus, USA) device. The treatment was carried out for 72 hours under rectal temperature control, which was maintained in the range of 34–350C. The treatment was conducted in accordance with the rules adopted in the ward and the study did not affect its course.
-
Collecting data
-
Clinical data: Based on the documentation from the delivery room, the type of delivery (natural/cesarean section), gender (male/female), gestational age (weeks), birth weight (grams), and Apgar scores in the 1., 5., and 10. minutes after birth were recorded.
-
Laboratory tests: Within 30 minutes of admission to the department, selected biochemical parameters were evaluated: pH (arterial blood), Aspartate Aminotranspherase (AspAt), Alanine Aminotranspherase (AlAt), Creatine Kinase [Muscle, Brain] (CKMB), High-Sensitivity Troponin T (HSTNT).
-
MRI assessment: The MRI was performed after the end of TH and after the newborn had reached a normal temperature. Brain MRI was performed with use of a 1,5 T scanner, using T1-, T2-weighted images, fluid-attenuated inversion recovery (FLAIR), inversion recovery (IR), susceptibility-weighted imaging (SWI) and diffusion-weighted imaging (DWI) sequences. The images were assessed using MRI score (MRIS) according to the scoring system proposed by Weeke et al.16. The higher score, the more serious brain injury. The lowest possible score was 0, and the highest was 55.
-
Thermal Index (TI): As described by Walas et al.32 the heat balance for the neonate undergoing TH reads
(1)
where Qm represents the rate of metabolic heat production, Qskin is the rate of heat dissipated through the skin (to the local indoor environment) while Qresp stands for the rate of heat exchanged due to respiration. These three heat rates are all expressed in watts (W). The time derivative on the right-hand side of the equation accounts for changes of neonate’s body internal energy U with respect to time. In the proposed study, internal energy U has been determined as a function of tissues temperatures (based on two terms related to skin and core compartment temperature measurements).
Summation of Qskin and Qresp represents the total heat rate exchanged by the neonate with cooling water and a local indoor environment. In case of the selective hypothermia, the dominant term of Qskin heat rate is the heat exchanged between neonate’s head and cooling water flowing through a cooling cap. Amount of heat Qcooling that is determined as the energy exchanged in this way in the early phase of TH (for instance during the first hour) can be treated as a driving quantity of TH process.
On the other hand, the decrease of neonate’s core temperature, or more precisely decrease of internal energy ΔU during the same time period can be seen as a direct effect of the cooling process. The ratio of these two quantities, i.e. ΔU and Qcooling, represents the effectiveness of the cooling process, which depends on the degree of brain damage. Finally, the above described ratio TI is related to neonate’s body weight W and scaled to make results comparable with the MRIS16 results:
(2)
Details how quantities of ΔU and Qcooling should be calculated based on non-invasive measurements during TH are given in the study by Walas et al.32.
Since the MRIS is measured on an ordinal scale, nonparametric tests were used. In order to investigate the relationship between the MRIS and other analyzed parameters, the Spearman rank correlation coefficient was calculated. Kendall's W coefficient of concordance with chi-square test was calculated to determine the agreement between the MRIS and the TI. First, however, the min-max normalization was used for MRIS, TI and pH to change their values to the range [0;1]. Statistica 12 by StatSoft and PQStat by PQStat Software were used.
The research is not a clinical trial and therefore does not need to be registered. The study protocol was consistent with the ethical guidelines of the Declaration of Helsinki and its later amendments and current EU guidelines and regulations. The study was approved by the Bioethics Committee for Research Studies at the Opole Medical Chamber (Approval No 271/2018 and 272/2018). Written informal consent was obtained from all legal guardians of all study participants.